Stelvio Therapeutics Company
Stelvio Oncology is focused on delivering precision medicine diagnostics and novel therapeutics for glioblastoma.
Investors
Technology:
['BioTech & HealthTech']
Headquarters:
San Diego, California, United States
Last Funding Date:
2017-05-05
Last Funding Type:
Seed
Founded Date:
2017-03-01
Investors Number:
2.0
Industry:
Medical BioTech
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Investor Type:
For Profit
Funding Status:
Seed